Cereno Scientific publishes interim report for Q1 2022
The Board and Chief Executive Officer of Cereno Scientific AB here presents the interim report for Q1, 1 January – 31 March, 2022. Summary of the first quarter, January – March 2022Cereno Scientific Group First quarter (1 January – 31 March 2022) · Net Sales were SEK 0 (0) · Result after financial items was SEK -5,246,969 (-3,903,947) · Earnings per share was SEK -0.05 (-0.05) before dilution and SEK -0.04 (-0.03) after dilution · The equity/assets ratio was 93.4% (87.2%) · Cash and bank balance was SEK 77,268,668 (60,071,685) Parent company First quarter (1